These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31165631)

  • 61. Variable selection in competing risks models based on quantile regression.
    Li E; Tian M; Tang ML
    Stat Med; 2019 Oct; 38(23):4670-4685. PubMed ID: 31359443
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An empirical comparison of statistical tests for assessing the proportional hazards assumption of Cox's model.
    Ng'andu NH
    Stat Med; 1997 Mar; 16(6):611-26. PubMed ID: 9131751
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A version of the EM algorithm for proportional hazard model with random effects.
    Abrahantes JC; Burzykowski T
    Biom J; 2005 Dec; 47(6):847-62. PubMed ID: 16450857
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tests for comparing mark-specific hazards and cumulative incidence functions.
    Gilbert PB; McKeague IW; Sun Y
    Lifetime Data Anal; 2004 Mar; 10(1):5-28. PubMed ID: 15130048
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The use of restricted mean time lost under competing risks data.
    Lyu J; Hou Y; Chen Z
    BMC Med Res Methodol; 2020 Jul; 20(1):197. PubMed ID: 32711456
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nomogram for survival analysis in the presence of competing risks.
    Zhang Z; Geskus RB; Kattan MW; Zhang H; Liu T
    Ann Transl Med; 2017 Oct; 5(20):403. PubMed ID: 29152503
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The estimation of average hazard ratios by weighted Cox regression.
    Schemper M; Wakounig S; Heinze G
    Stat Med; 2009 Aug; 28(19):2473-89. PubMed ID: 19472308
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cause-Specific Hazard Regression for Competing Risks Data Under Interval Censoring and Left Truncation.
    Li C
    Comput Stat Data Anal; 2016 Dec; 104():197-208. PubMed ID: 28018017
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Planning and analyzing clinical trials with competing risks: Recommendations for choosing appropriate statistical methodology.
    Poythress JC; Lee MY; Young J
    Pharm Stat; 2020 Jan; 19(1):4-21. PubMed ID: 31625290
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A weighted combined effect measure for the analysis of a composite time-to-first-event endpoint with components of different clinical relevance.
    Rauch G; Kunzmann K; Kieser M; Wegscheider K; König J; Eulenburg C
    Stat Med; 2018 Feb; 37(5):749-767. PubMed ID: 29205425
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Validation of a heteroscedastic hazards regression model.
    Wu HD; Hsieh F; Chen CH
    Lifetime Data Anal; 2002 Mar; 8(1):21-34. PubMed ID: 11878222
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mixed-effects varying-coefficient model with skewed distribution coupled with cause-specific varying-coefficient hazard model with random-effects for longitudinal-competing risks data analysis.
    Lu T; Wang M; Liu G; Dong GH; Qian F
    J Biopharm Stat; 2016; 26(3):519-33. PubMed ID: 26097990
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Estimating restricted mean survival time and expected life-years lost in the presence of competing risks within flexible parametric survival models.
    Mozumder SI; Rutherford MJ; Lambert PC
    BMC Med Res Methodol; 2021 Mar; 21(1):52. PubMed ID: 33706711
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of the marginal hazard model and the sub-distribution hazard model for competing risks under an assumed copula.
    Emura T; Shih JH; Ha ID; Wilke RA
    Stat Methods Med Res; 2020 Aug; 29(8):2307-2327. PubMed ID: 31868107
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A competing risks model for correlated data based on the subdistribution hazard.
    Dixon SN; Darlington GA; Desmond AF
    Lifetime Data Anal; 2011 Oct; 17(4):473-95. PubMed ID: 21603882
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of delayed graft function on graft and patient survival in kidney transplantation: an approach using competing events analysis.
    Fonseca I; Teixeira L; Malheiro J; Martins LS; Dias L; Castro Henriques A; Mendonça D
    Transpl Int; 2015 Jun; 28(6):738-50. PubMed ID: 25689397
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Local influence for the subdistribution of a competing risk.
    Resche-Rigon M; Chevret S
    Stat Med; 2006 Jun; 25(11):1937-47. PubMed ID: 16158402
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Semiparametric regression on cumulative incidence function with interval-censored competing risks data.
    Bakoyannis G; Yu M; Yiannoutsos CT
    Stat Med; 2017 Oct; 36(23):3683-3707. PubMed ID: 28608412
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of different parametric proportional hazards models for interval-censored data: a simulation study.
    Gong Q; Fang L
    Contemp Clin Trials; 2013 Sep; 36(1):276-83. PubMed ID: 23916917
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Applying the Cox proportional hazards model when the change time of a binary time-varying covariate is interval censored.
    Goggins WB; Finkelstein DM; Zaslavsky AM
    Biometrics; 1999 Jun; 55(2):445-51. PubMed ID: 11318198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.